HER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for HER2 testing if the cancer is invasive, metastatic, and/or recurrent.

Cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to ...

The HER-2/neu oncogene encodes a 185 Kd tyrosine kinase (TK) receptor and belongs to the type 1 receptor family that includes the epidermal growth factor receptor, HER-3, and HER-4. These ...

DCIS is a non-invasive or pre-invasive breast cancer, meaning the cancer cells are confined to the milk ducts and haven’t ...

Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with a higher risk of developing luminal-like breast cancer subtypes and other ...

Access free, up-to-date clinical references about the pathophysiology and molecular pathways of HER2-positive breast cancer. Healio's Clinical Guidance content provides valuable insights for ...

AI could help pathologists identify HER2-low and HER2-ultralow breast cancers with greater accuracy, according to findings scheduled for presentation at ASCO Annual Meeting.In a study of more than ...

We identified GPRC5A and TPBG as potential biomarkers for a poor response to anti-HER2 therapy.” “Our proteogenomic analysis of CALGB 40601 revealed likely false-positives among patients diagnosed ...